New patent expiration for Acrotech drug MARQIBO KIT
Annual Drug Patent Expirations for MARQIBO+KIT Marqibo Kit is a drug marketed by Acrotech and is included in one NDA. […]
New patent expiration for Acrotech drug MARQIBO KIT Read Post »
Patent Expiration
Drug Patent Expirations for the Week of September 20, 2020
MARQIBO KIT (vincristine sulfate) Acrotech Patent: 7,247,316 Expiration: Sep 25, 2020 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of September 20, 2020 Read Post »
New patent expiration for Endo Pharms drug MEGACE ES
Annual Drug Patent Expirations for MEGACE+ES Megace Es is a drug marketed by Endo Pharms Inc and is included in
New patent expiration for Endo Pharms drug MEGACE ES Read Post »
New patent expiration for Abbvie drug TRICOR
Annual Drug Patent Expirations for TRICOR Tricor is a drug marketed by Abbvie and Abbvie Inc and is included in
New patent expiration for Acorda drug INBRIJA
Annual Drug Patent Expirations for INBRIJA Inbrija is a drug marketed by Acorda and is included in one NDA. It
Drug Patent Expirations for the Week of September 13, 2020
BEVYXXA (betrixaban) Portola pharms inc Patent: 9,629,831 Expiration: Sep 15, 2020 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of September 13, 2020 Read Post »
New patent expiration for Portola Pharms drug BEVYXXA
Annual Drug Patent Expirations for BEVYXXA Bevyxxa is a drug marketed by Portola Pharms Inc and is included in one
New patent expiration for Portola Pharms drug BEVYXXA Read Post »
Patent delisted for Merck Sharp drug PREVYMIS
Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two
Patent delisted for Boehringer Ingelheim drug TRIJARDY XR
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one
Patent delisted for Boehringer Ingelheim drug TRIJARDY XR Read Post »
